Related Experiment Videos
Simplified Reverse Dot Blot Analyses for Detecting of ras Oncogene Mutations
1Section of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Abstract:
Background: Mutations in members of the ras gene family (H-ras, K-ras, and N-ras) have been identified in various human malignancies. A variety of techniques have been used to test for ras mutations. Methods and Results: A simplified reverse dot blot (RDB) assay was used in this study. Polymerase chain reaction products were hybridized to nitrocellulose membrane-fixed synthetic probes (20 nucleotides long) specific for codons 12, 13, and 61 of H-, K-, and N-ras mutations and their wild-type sequences. No special treatment or modification of the probes was necessary to obtain adequate results in overnight film exposure when the polymerase chain reaction was carried out using (32)P-end labeled primers. It was demonstrated that this simplified RDB assay can also be used with fluorescein-11-dUTP and a chemiluminescence detection system. The RDB assay is more reliable than the single-strand conformation polymorphism (SSCP) assay. By comparison, the SSCP assay is significantly less sensitive and less specific. It was confirmed with sequencing that 11 (12%) of 93 SSCP assays were false positive and 2 (2%) were false negative, whereas no false positive or false negative RDB assay was detected. The RDB assay also provides more additional detailed information about the specific point mutation and amino acid change, which may have clinical implications in some tumors. Conclusions: The RDB assay is very sensitive and able to detect mutations when the mutant allele is in 1% of the cells and can be used to detect minimal residual disease, particularly in some cases of leukemia and myelodysplasia.
Insights
The simplified reverse dot blot (RDB) assay reliably detects ras gene mutations, outperforming single-strand conformation polymorphism (SSCP) assays. This sensitive method aids in identifying minimal residual disease, especially in leukemia.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Ras gene family mutations (H-ras, K-ras, N-ras) are prevalent in human cancers.
- Accurate detection of these mutations is crucial for diagnosis and treatment.
- Existing methods for ras mutation detection have limitations.
Purpose of the Study:
- To evaluate a simplified reverse dot blot (RDB) assay for detecting ras gene mutations.
- To compare the reliability and sensitivity of the RDB assay against the single-strand conformation polymorphism (SSCP) assay.
Main Methods:
- Utilized a simplified reverse dot blot (RDB) assay with polymerase chain reaction (PCR) products hybridized to specific probes.
- Tested probes for codons 12, 13, and 61 of H-, K-, and N-ras mutations and wild-type sequences.
- Assessed RDB assay performance using both radioactive ((32)P) and chemiluminescent detection systems.
Main Results:
- The RDB assay demonstrated high sensitivity, detecting mutations when the mutant allele comprised only 1% of cells.
- Compared to SSCP, the RDB assay proved significantly more reliable, sensitive, and specific, with no false positives or negatives.
- SSCP assays showed a 12% false positive rate and a 2% false negative rate when validated by sequencing.
Conclusions:
- The simplified RDB assay is a highly sensitive and accurate method for detecting ras gene mutations.
- This assay provides detailed information on specific point mutations and amino acid changes, potentially aiding clinical decision-making.
- The RDB assay's sensitivity makes it suitable for detecting minimal residual disease, particularly in leukemia and myelodysplasia.